Lewis, D. J., Palomba, M. L., Patel, M. R., Eyre, T. A., Jurczak, W., Gastinne, T., … Cheah, C. Y. (2023). Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia. In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 201, pp. 109–110).

Lewis, David John, M Lia Palomba, Manish R. Patel, Toby A. Eyre, Wojciech Jurczak, Thomas Gastinne, Shuo Ma, et al. “Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia.” In BRITISH JOURNAL OF HAEMATOLOGY, 201:109–10, 2023.

Lewis DJ, Palomba ML, Patel MR, Eyre TA, Jurczak W, Gastinne T, et al. Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia. In: BRITISH JOURNAL OF HAEMATOLOGY. 2023. p. 109–10.

Lewis, David John, et al. “Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia.” BRITISH JOURNAL OF HAEMATOLOGY, vol. 201, 2023, pp. 109–10.

Lewis DJ, Palomba ML, Patel MR, Eyre TA, Jurczak W, Gastinne T, Ma S, Cohen JB, Patel K, Brown JR, Scarfo L, Munir T, Lech-Maranda E, Hoffmann MS, Ujjani CS, Fakhri B, Wang M, Izutsu K, Nagai H, Tam CS, Seymour JF, Rhodes JM, Vose J, McKinney M, Gerson JN, Barve MA, Kuss B, Koh Y, Gao W, Ruppert AS, Walgren RA, Tsai DE, Nair B, Bao K, Mato AR, Cheah CY. Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia. BRITISH JOURNAL OF HAEMATOLOGY. 2023. p. 109–110.